The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of ...
How effective is it? In an American clinical trial, women wore the patch for 12 hours a day. Out of 79 women who suffered from moderate to severe menstrual pain, they were tested in three ways.
A new study published in The Journal of the American Dental Association found that a combination of over-the-counter pain relievers is more effective in pain management after wisdom teeth extractions ...